Literature DB >> 16311217

Mineralocorticoid-stimulating activity of adipose tissue.

Valeria Lamounier-Zepter1, Monika Ehrhart-Bornstein, Stefan R Bornstein.   

Abstract

Obesity is strongly associated with arterial hypertension. A positive correlation between obesity and plasma aldosterone levels has been observed by different investigators, suggesting that an abnormal secretion of aldosterone in obesity contributes to the development of arterial hypertension in obese subjects. The mechanisms proposed to explain this abnormal aldosterone production mainly involve the adipose renin-angiotensin system, an indirect effect of increased fatty acids, and direct adrenal stimulation by adipocyte secretory products. Indeed, adipose mineralocorticoid-stimulating activity was recently observed in isolated human adipocytes, suggesting a hitherto unknown direct involvement of adipose tissue in the regulation of blood pressure in obesity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311217     DOI: 10.1016/j.beem.2005.07.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  8 in total

Review 1.  Aldosterone Production and Signaling Dysregulation in Obesity.

Authors:  Andrea Vecchiola; Carlos F Lagos; Cristian A Carvajal; Rene Baudrand; Carlos E Fardella
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

Review 2.  Mineralocorticoid receptor antagonists and the metabolic syndrome.

Authors:  Amir Tirosh; Rajesh Garg; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

3.  Blood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism.

Authors:  Helge Müller-Fielitz; Margot Lau; Olaf Jöhren; Florian Stellmacher; Markus Schwaninger; Walter Raasch
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

4.  Identifying treatment response to antihypertensives in patients with obesity-related hypertension.

Authors:  Ilse M Schrover; Jannick A N Dorresteijn; Jodine E Smits; A H Jan Danser; Frank L J Visseren; Wilko Spiering
Journal:  Clin Hypertens       Date:  2017-10-24

5.  Vascular disease in an expanding world: seeking answers inside and outside of the box.

Authors:  James A Sloand; John D Bisognano
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-04       Impact factor: 3.738

6.  Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism.

Authors:  Adam P McGraw; Jessamyn Bagley; Wei-Sheng Chen; Carol Galayda; Heather Nickerson; Andrea Armani; Massimiliano Caprio; Peter Carmeliet; Iris Z Jaffe
Journal:  J Am Heart Assoc       Date:  2013-02-22       Impact factor: 5.501

Review 7.  Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone.

Authors:  N Muñoz-Durango; A Vecchiola; L M Gonzalez-Gomez; F Simon; C A Riedel; C E Fardella; A M Kalergis
Journal:  Biomed Res Int       Date:  2015-09-10       Impact factor: 3.411

8.  Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division.

Authors:  Andrea Vecchiola; Cristóbal A Fuentes; Isidora Solar; Carlos F Lagos; Maria Cecilia Opazo; Natalia Muñoz-Durango; Claudia A Riedel; Gareth I Owen; Alexis M Kalergis; Carlos E Fardella
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-21       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.